Ishida Tadashi, Tachibana Hiromasa, Ito Akihiro, Tanaka Maki, Tokioka Fumiaki, Furuta Kenjiro, Nishiyama Akihiro, Ikeda Satoshi, Niwa Takashi, Yoshioka Hiroshige, Arita Machiko, Hashimoto Toru
Dept. of Respiratory Medicine, Kurashiki Central Hospital, Kurashiki, Japan.
Dept. of Respiratory Medicine, Kurashiki Central Hospital, Kurashiki, Japan.
J Infect Chemother. 2014 Aug;20(8):471-6. doi: 10.1016/j.jiac.2014.04.005. Epub 2014 Jun 18.
Unlike elderly patients with community-acquired pneumonia whose outcomes are markedly affected by their background characteristics, it appears that the severity of the infection itself contributes to outcomes in younger patients with community-acquired pneumonia. In order to identify clinical characteristics of severe community-acquired pneumonia in younger patients under 60 years old, among such cases prospectively collected at our hospital over a period of 18 years, those meeting the criteria for severe community-acquired pneumonia, as defined in the Infectious Diseases Society of America/American Thoracic Society Guidelines for community-acquired pneumonia, were retrospectively examined and compared to elderly patients with severe community-acquired pneumonia. Younger patients with severe pneumonia accounted for 12.9% of younger hospitalized patients. Although the incidence of severe pneumonia in younger patients was lower than that in elderly patients, its severity may be underestimated by severity assessment based on the conventional guidelines. Thus, attention is required. While Streptococcus pneumoniae and Legionella species were important causative pathogens, atypical pathogens and viruses were also frequently detected. There were only 11 deaths over a period of 18 years. Based on multivariate analysis, the risk factors for aggravation of community-acquired pneumonia among younger patients were age 50 years or older, diabetes mellitus, chronic liver disease, and Legionella pneumonia. Although the mortality rate from community-acquired pneumonia is extremely low in previously healthy younger patients, outcomes might be poor for patients with underlying diseases and those with rapid progression. Multimodal treatments including respiratory management may be appropriate.
与社区获得性肺炎老年患者的预后明显受其背景特征影响不同,似乎感染本身的严重程度对社区获得性肺炎年轻患者的预后有影响。为了确定60岁以下年轻患者中重症社区获得性肺炎的临床特征,在我院18年间前瞻性收集的此类病例中,对符合美国传染病学会/美国胸科学会社区获得性肺炎指南中定义的重症社区获得性肺炎标准的患者进行回顾性检查,并与重症社区获得性肺炎老年患者进行比较。重症肺炎年轻患者占年轻住院患者的12.9%。虽然年轻患者中重症肺炎的发病率低于老年患者,但其严重程度可能被基于传统指南的严重程度评估所低估。因此,需要予以关注。虽然肺炎链球菌和军团菌属是重要的致病病原体,但非典型病原体和病毒也经常被检测到。18年间仅有11例死亡病例。基于多因素分析,年轻患者社区获得性肺炎病情加重的危险因素为年龄50岁及以上、糖尿病、慢性肝病和军团菌肺炎。虽然在既往健康的年轻患者中社区获得性肺炎的死亡率极低,但有基础疾病的患者以及病情进展迅速的患者预后可能较差。包括呼吸管理在内的多模式治疗可能是合适的。